Owen’s Story: How a Toy Doctor’s Kit Led to a Rare Cancer Diagnosis
The first signs of a problem came on Owen’s third birthday. His grandma gave him a toy doctor’s kit as a gift, and while Owen and his mom, Chelsea, played with the eye chart, Chelsea noticed Owen became frustrated when she covered his right eye and asked him to use his left to read the letters.
“He kept saying, ‘I can’t see, I can’t see,’” Chelsea said. “I’d tell him, ‘You can do it, buddy. You just did it with your right eye. Now do it with this one.’”
After the same thing happened three days in a row, Owen’s dad, Andrew, suggested they make an eye appointment.
Chelsea and Andrew took him to an eye doctor in Miamisburg near their home in Carlisle, Ohio. She referred Owen to Cincinnati Children’s, anticipating they’d likely hear from someone in a few weeks to schedule an appointment. But an hour later, the doctor called again. She told Chelsea that Cincinnati Children’s could see Owen on Monday, and they should take the day off work.
“That’s when we started panicking,” Chelsea said.
Quick Answers and a Treatment Plan
At Cincinnati Children’s, an exam revealed a mass in Owen’s left eye. Additional testing confirmed he had retinoblastoma, a cancer that develops in the retina—the light-sensitive tissue at the back of the eye.
Thankfully, the cancer was confined to Owen’s left eye and had not reached his right eye or brain.
“That was the silver lining,” said Raehannah Jamshidi-Nezhad, MD, PhD, a pediatric oncologist who leads Cincinnati Children’s retinoblastoma team, which also includes Zeynep Gursel, MD, a pediatric ocular oncologist and Sudhakar Vadivelu, DO, a pediatric neurosurgeon.
Although the cancer hadn’t spread, Owen’s case was complex. The tumor had released many tiny clusters of cancer cells, known as vitreous seeds, into the gel-like substance filling his eye.
“There were so many seeds we couldn’t even see the back of the eye,” Dr. Gursel said. “It looked like a white cloud.”
The retinoblastoma team met with the family and outlined their proposed treatment plan: a combination of chemotherapy delivered straight to the arteries behind the eye, called intra-arterial chemotherapy, and chemotherapy administered directly into the fluid inside the eye, called intravitreal chemotherapy.
“Within a week, we had all the answers, all the tests done, and an idea of what the future would hold,” Chelsea said.



